Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Evidence of lost baptismal rite stage uncovered in Byzantine era cathedral near Sea of Galilee - 2Ifo: Job cuts in Germany slowing but not enough for a turnaround
- 3Kids who get 2-month vaccines on time 7 times more likely to receive MMR shot: Study
- 4Pick Your Favored kind of books
- 56 Useful Home Espresso Machines
- Step into Nature: A Survey of \Handling Trails with Solace\ Climbing Shoes
- The Latest: Fueling begins as NASA aims to send 1st crew to the moon in 53 years
- The most effective method to Go Down Abundance through Ages with Disc Rates
- Hilary Duff releases 'Mature,' her 1st song in 10 years
- Kona SUV: Exploring the Future with Hyundai's Visionary Hybrid
- Fossils unearthed in Morocco are first from little-understood period of human evolution
- Before trips to Mars, we need better protection from cosmic rays
- Sa'ar warns German delegation: 'A Palestinian state would be a Hamas terror state'
- Chinese construction workers in Israel: 'I’d rather be bombed than live in poverty'
